(Q77631000)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9837939%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

title

Covalent heparin cofactor II-heparin and heparin cofactor II-dermatan sulfate complexes. Characterization of novel anticoagulants (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9837939%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9837939%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Anthony K. C. Chan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9837939%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

author name string

L Berry

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9837939%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

H O'Brodovich

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9837939%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

M Andrew

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9837939%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

language of work or name

English

0 references

publication date

1 December 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9837939%20AND%20SRC:MED&resulttype=core&format=json

Journal of Biological Chemistry

7 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9837939%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

273

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9837939%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9837939%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

33566-33571

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9837939%20AND%20SRC:MED&resulttype=core&format=json

The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin

7 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.50.33566

Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.50.33566

Arginine 200 of heparin cofactor II promotes intramolecular interactions of the acidic domain. Implication for thrombin inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.50.33566

Glycosaminoglycans and the regulation of blood coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.50.33566

Increased sulphation improves the anticoagulant activities of heparan sulphate and dermatan sulphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.50.33566

Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: implications for heparin efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.50.33566

Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.50.33566

Binding of fibrin monomer and heparin to thrombin in a ternary complex alters the environment of the thrombin catalytic site, reduces affinity for hirudin, and inhibits cleavage of fibrinogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.50.33566

Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.50.33566

A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.50.33566

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.50.33566

Hypercoagulability in premature infants with special reference to the respiratory distress syndrome and hemorrhage. I. Coagulation studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.50.33566

Intrapulmonary heparin. A new procedure for anticoagulant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.50.33566

Osteopenia in pregnancy during long-term heparin treatment: a radiological study post partum

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.50.33566

A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.50.33566

A retrospective study of the pharmacokinetics of heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.50.33566

Simultaneous determination of dermatan sulfate and oversulfated dermatan sulfate in plasma by high-performance liquid chromatography with postcolumn fluorescence derivatization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.50.33566

Covalent antithrombin-heparin complexes with high anticoagulant activity. Intravenous, subcutaneous, and intratracheal administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.50.33566

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.50.33566

An improved method of sequential alcian blue and ammoniacal silver staining of chondroitin sulfate proteoglycan in polyacrylamide gels

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.50.33566

Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.50.33566

Tritiation of commercial heparins by reaction with NaB3H4: chemical analysis and biological properties of the product

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.50.33566

Efficacy of an intravenous low-molecular-weight dermatan sulphate (Desmin) in patients with acute proximal deep venous thrombosis and silent pulmonary embolism. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.50.33566

21 January 2018

Identifiers

DOI

10.1074/JBC.273.50.33566

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9837939%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference